Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Choosing the right monthly auto contribution rate for retirement can balance present needs with future security. Learn how to set a practical, persistent rate now.
18,528 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When the market's fear gauge just spiked, investors wonder what comes next for AI stocks. This guide breaks down the ...
Teaching money early doesn’t have to be complicated. These four money lessons your kids can learn before kindergarten...
As UnitedHealth readies its 2026 earnings, investors want clarity on growth, margins, and risk. This guide breaks dow...
Reliance Industries sits at the center of India’s growth story. This guide breaks down reliance (rs) 2025 earnings ex...
Palantir is venturing into a new market via Polymarket, sparking questions about its AI growth path. This guide lays ...
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
Investors rushed to understand why intuitive surgical stock dropped this week. This article dissects the catalysts, g...
Wheels Up Experience is in the spotlight as its stock faces a sharp decline. This article breaks down the primary cau...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
The vnet 2025 earnings call laid out a clear path for growth and profitability in a competitive cloud market. This an...
Afriski, Lesotho's country’s only fully operational ski resort, keeps winter tourism alive and feeds local incomes as...